Moderators:Snorri S. Thorgeirsson,Jack R. Wands

-	Viral Pathogens and Human Hepatocellular Carcinoma		Xin-wei Wang (王心伟)
-	Oncogenic Role of HBV "X" Gene in the Pathogenesis of HCC		Xin-yuan Guan (关新元)
-	Dysplastic Lesion and Early Hepatocellular Carcinoma		Wen-min Cong (丛文铭)
-	Pathological Diagnosis of HCC and Beyond		Irene O.L. Ng (吴爱莲)
-	Stem Cell and HCC		Xiao-dong Zhang (张晓东)

Moderators:Josep M.Llovet,Samuel So

-	Optimal Screening Strategy		Bo-heng Zhang (张博恒)
-	Modern Imaging Technologies: Contrast Ultrasonography, MRI, CT		Byung-ihn Choi
-	Biomarker: from Molecular Profiling to Clinical Prediction		Lun-xiu Qin (钦伦秀)
-	Clinical Staging		Jordi Bruix
-	Molecular Pathogenesis of Hepatocellular Carcinoma		Snorri S. Thorgeirsson

Moderators:Hui-chuan Sun,Jordi Bruix

-	Liver Resection: Indications and Techniques		Ronnie T.P. Poon (潘冬平)
-	Laparoscopic Liver Resection		Hong-yaw Chen (陈鴻曜)
-	Liver Transplantation for HCC		Chung-mau Lo (卢宠茂)
-	The Role of Percutance Radiofrequency Ablation in the Treatment of Small Hepatocellular Carcinoma		Min-shan Chen (陈敏山)
-	Debate Session - Treatment for Small HCC: Resection, Transplant, or RFA?

Moderators:Ronnie T.P. Poon (潘冬平), Joseph W.Y. Lau (刘允怡)

-	Transcatheter Arterial Chemoembolization (TACE)		Joseph M. Llovet
-	High-intensity Focused Ultrasound Ablation for Patients with Liver Cancer		Feng Wu (伍烽)
-	Radiotherapy for HCC		Zhao-chong Zeng (曾昭冲)
-	Anti-angiogenesis Therapy		Ronnie T.P. Poon (潘冬平)
-	Molecular Target Therapy		Jack R. Wands

Moderators: Shiu-kum Lam (林兆鑫), Sheng-long Ye (叶胜龙)

-

Drugs Discovery in Liver Diseases

Yung-chi Cheng (郑永齐)

Moderators:F. Blaine Hollinger, Hui Zhuang (庄辉)

-	HCC - Review and Prospect		Zhao-you Tang (汤钊猷)
-	Primary Biliary Cirrhosis in China		Guang-bi Yao (姚光弼)

Moderators: Zai-ping Li(李载平), Meng-chao Wu (吴孟超)

-	Liver Transplantation for HCC		Sheung-tat Fan (范上达)
-	P53 Tumor Suppressor Network : At the Crossroads of the Molecular Carcinogenesis and Molecular Epidemiology of Liver Cancer		Curtis C. Harris
-	Advances in the Treatment of Hepatitis C		Eugene R. Schiff
-	Global Challenges in Liver Disease		Roger S. Williams

Moderators: Jordi Bruix, Zhao-you Tang (汤钊猷)

-	Surgical Treatment		Meng-chao Wu (吴孟超)
-	Surgical Techniques in Liver Resection		Henri Bismuth
-	Early Diagnosis and Treatment of Hepatocellular Carcinoma and managerment of its Recurrence		Xin-da Zhou
-	Liver Transplantation: Beyond Milan Criteria		Shu-sen Zheng (郑树森)
-	Survival Analysis after Surgical Treatment for HCC		Ronnie T.P. Poon (潘冬平)
-	Resection or Liver Transplantation for Small HCC with Child's A Cirrhosis		Sasan Roayaie

Moderators: Laurentius A. Lesmana, Zhi-meng Lu (陸志檬)

-	Virological Assessment of HBV		Stephen A. Locarnini
-	Fibroblast Activation Protein : A Novel Cell Surface Protease on Human Stellate Cells		Geoffrey W. McCaughan
-	Clinical Applications of HCV Kinetic Study		Alan S. Perelson
-	Clinical Application of An Ex-vivo Liver Slice Assay in Patients with Viral Hepatitis		Chau-ting Yeh(叶昭廷)
-	Functional Analysis of Full Length Genome of HBV in Understanding the Pathogenesis with Viral Hepatitis		Yu-mei Wen (闻玉梅)
-	Role of cccDNA in Monitoring of Therapy for HBV		Joseph J.Y. Sung (沈祖尧)
-	Application of Viral Load Measurement in HCV Patients on Antiviral Therapy		Robert G. Gish
-	Mechanism of Interferon Resistance in Hepatitis C		T. Jake Liang

Moderators: Eddie C.Cheung

-	Viral Suppression		Eddie C. Cheung
-	Resistances -U.S Experiences on Entecavir            Calvin Q. Pan		Daryl T.Y. Lau
-	Treatment of Options		Eugene R. Schiff

Moderators: Ronnie T.P.Poon, Sum P.Lee

-	Prevention of HCC		Jordi Bruix
-	Screening of HCC		Massimo Colombo
-	Immunosuppression in Liver Transplantation		John J. Fung
-	Liver Cancer: Hepatocarcinogenesis and Treatment Modality		Chen-guo Ker (柯成国)
-	Imaging for HCC		Byung-ihn Choi
-	DNA and Tissue Microarrays Combined with Gene Ontology Analysis to Identify Potential Diagnostic and Treatment Targets in Primary HCC		Samuel So

Moderators: Michael P. Manns, Xin-hui Weng (翁心華)

-	Treatment of Hepatitis B e Antigen Negative Disease		Pactrick Marcellin
-	Hepatitis B Treatment: Are More Options Better		Nancy W.Y. Leung (梁慧仪)
-	Design of Combination Therapy for Chronic HBV Infection		Nikolai V. Naoumov
-	Treatment of Hepatitis B e Antigen Positive Disease		George K.K. Lau (廖家杰)
-	(Peg) interferon for Chronic HBeAg-positive HBV: Integration of Findings from 3 Randomized Controlled Trials		Solko W. Schalm
-	Long-term Follow up - Interferon Vs Lamivudine Vs Adefovir		Rong-nan Chien (简荣南)

Moderators: Henri Bismuth, Chung-mau Lo (卢宠茂)

-	Microwave Coagulation Therapy for HCC		Bao-wei Dong (董宝玮)
-	Clinical and Basic Research - the Prevention of Recurrence of Post-operative HCC		Feng Shen (沈锋)
-	Multidisciplinary Treatment for Advanced Hepatocellular Carcinoma with Major Portal Thrombosis		Morito Monden
-	Nonsurgical Multimodality Therapy in Advanced Inoperable HCC		Kwang-hyub Han
-	40-years Experience in the Management of Primary Liver Carcinoma		Jin-qing Li(李錦清)
-	Transcatheter Arterial Thrombolysis for the Treatment of Early Hepatic Artery Thrombosis after Liver Transplantation		Jian Zhou (周俭)
-	Radiotherapy for HCC-6-year Experience in Zhongshan Hospital		Zhao-chong Zeng (曾昭冲)
-	Glypican-3 Testing and the Diagnosis of Hepatocellular Carcinoma		Ronald D. Guttmann

Moderators: Edward J. Gane, Hui Zhuang (庄辉)

-	Hepatologists in Asia: A Rare Breed No More!		George K.K. Lau (廖家杰)
-	Geographic and Epidemiological Pecularities of Hepatology Practice in Asia		Shiv K. Sarin
-	A Viable Hepatology Training Program in the Asia-Pacific: Strategies and Mechanics		Jose D. Sollano
-	Future Directions of Asian Hepatology of Samll Hepatocellular Carcinoma		Masao Omata

Moderators: Daryl T.Y. Lau, Ji-yao Wang(王吉耀)

-	Nucleos(t)ide Analogue as First-line Therapy (Pro)		Robert G. Gish
-	Nucleos(t)ide Analogue as First-line Therapy (Con)		Solko W. Schalm

Moderators: Pei-jer Chen (陈培哲), Chi-kuen Chan (陈志权)

-	NALT CHC Need to Be Treated (Pro)		Alfredo Alberti
-	NALT CHC Need to Be Treated (Con)		Marion G.Peter

Moderator: W. Graham Cooksley, Zhi-meng Lu (陆志檬)

-	Combination Therapy Is Better than Monotherapy in Chronic HBV Infection (Pro)		Shiv K. Sarin
-	Combination Therapy Is Better than Monotherapy in Chronic HBV Infection (Con)		Edward J. Gane

Moderators: Zhao-you Tang (汤钊猷),Xin-wei Wang (王心伟)

-	Liver Fibrogenesis		David A. Brenner
-	Apoptosis and HCC		Peter R. Galle
-	The Molecular Signatures of Metastases of Human HCC		Xin-wei Wang (王心伟)
-	Comparative Functional Genomics Genomics of HCC		Snorri S. Thorgeirsson
-	Predictive Biomarkers for Metastatic Recurrence of human Hepatocellular Carcinoma		Lun-xiu Qin (钦伦秀)
-	Perspectives		Edison T. Liu

Moderators: Cheng-wei Chen (陈成伟), Leonard B. Seeff

-	Pathogenesis of Alcoholic Liver Disease		Amin A. Nanji
-	Safety of Complementary Japanese Medicine in Liver Disease		Osamu Yokosuka
-	Herb-induced Toxicity		Ismail Merican
-	Safety and Efficiency of Maintenance Therapy for HBV		Anuchit Chutaputti
-	Drug-induced Hepatotoxicity		Shiv K. Sarin
-	Side Effects of Antiviral Treatment - How to Deal with Them		Michael P. Manns
	Panel Discussion

Moderators: Yuan Wang (汪垣), Solko W. Schalm

-	Innate Immunity and ISG Expression in HCV		Daryl T.Y. Lau
-	Adaptive Immune Response to HBV		Sharon Lewin
-	Immunological Response with Antiviral Therapy in Chronic HBV		W. Graham Cooksley
-	Is there a clinicopathological role of a newly identified hepatotropic virus?		Chau-ting Yeh (叶昭廷)
-	Viral & Genetic Factors in HBV Related HCC		Pei-jer Chen (陈培哲)
-	Modulation of Immune Responses of Chronic Hepatitis B Patients by HBsAg-HBIG Complex (Yeast-derived HBsAg-anti-HBs)		Yu-mei Wen (闻玉梅)

Moderators: Yao Tong (童瑤), Bao-en Wang (王宝恩)

-	Antifibotic Therapy with Herbal Medicine:Concensus and Controversy		Ji-dong Jia (贾继东)
-	Can Traditional Chinese Medicine be Used to Treat Liver Fibrosis?		Jing-min Zhao (趙景民)
-	Prevention of Fibrosis Progression in Viral Hepatitis		Geoffrey W. McCaughan
-	Non-invasive Assessment of Liver Fibrosis		Kwang-hyub Han
-	How to Approach Studies with TCM on Liver Fibrosis		Ping Liu (刘平)
-	Fibroscan® Introduction		Stan Dembinski

Moderators: Mark A. McNiven, Lewis R. Roberts

-	Hepatocellular vesicle-protein traffic as an important mediator of viral infection		Mark A. McNiven
-	A new HCV culture model and its implication in studying virus-cell interaction		T. Jake Liang
-	Heparin-degrading endosulfatases in the pathogenesis of hepatocellular carcinoma: Novel paradigms in cancer cell signaling		Lewis R. Roberts
-	Wnt/frizzled/beta catenin signaling mediates cell migration and invasion in hepatocellular carcinoma		Jack R. Wands
-	The role of hepatic stellate cells in hepatic fibrosis		David A. Brenner
-	Modulation of apoptotic pathways by hepatitis B and C virus		Peter R. Galle

Moderators: Jin-lin Hou (侯金林), Sharon Lewin

-	Management of Treatment Refractory HBV		Wan-cheng Chow (周蕴菁)
-	What do we know about Comination Therapy in 2006		Eddie C. Cheung
-	siRNA for Treatment of HBV		Pei-jer Chen(陈培哲)
-	Appropriate Use of Interfeon in the Treatment of Asian Hepatitis B Patients		Jia-horng Kao (高嘉宏)
-	Predictors of Response to Therapy in HBV		Teerha Piratvisuth
-	Aim of HBV Treatment: Immunological Control or Viral Suppression?		Nikolai V. Naoumov
-	Anti-Viral Therapy and Natural History of HBV		Richard Y.C. Guan
-	Immunomodulattory Therapy for HBV		Daniel Shouval

Moderators: W. Graham Cooksley, Nancy W.Y. Leung (梁慧仪)

-	Increasing Evidence of the Effectiveness of Antifibrotic Treatment with TCM		Bao-en Wang
-	Liver Biopsy and New Emerging Non-invasive Methods for the Diagnosis of Liver Fibrosis		Laurentius A. Lesmana
-	Stem Cell in the Treatment of Liver Fibrosis		Lai Wei (魏来)
-	Viral Suppression in Chronic HBV Infection and Effect on Histological Outcome		Herve Mommeja-Marin
-	Progression of Liver Fibrosis in China		Kang-xian Luo (骆抗先)
-	Non-invasive Prediction of Liver Fibrosis		Karen L. Lindsay

Moderators: Massimo Colombo, Sheng-Long Ye (叶胜龙)

-	Downstaging of HCC		Joseph W.Y. Lau (刘允怡)
-	Percutaneous Ethanol Injection (PEI) and Radiofrequency Ablation(RFA)		Masao Omata
-	Resection as a Bridge to Liver Transplantation		Rene Adam
-	Medical Treatment		Hubert E. Blum
-	Prevention of HBV Recurrence after Liver Transplantation		Chung-mau Lo (卢宠茂)
-	RFA vs TACE for HCC		Guang-shun Yang (杨广顺)

Moderators: Faleh Al Faleh, Khaled Selim

-	Hepatitis C Epidemiology in Middle East		Gamal Esmat
-	HCV Genotype 4: Acute Hepatitis		Sanaa M. Kamal
-	HCV Genotype 4: Chronic Hepatitis		Fuad Hassan
-	Hepatitis B in Middle East		Imam Waked
-	Hepatitis B in the Kingdom of Saudi Arabia		Faleh Al Faleh
-	Hepatocellular Carcinoma in the Middle East		Khaled Selim
-	Pediatric Liver Diseases in Middle East		Tawhida Abul Ghaffar
-	Liver Transplantation in Middle East		Mohamed Al Sebayel
-	Discussion and Closing Remarks		Sanaa Kamal, Khaled Selim

Moderators: Brian I. Carr, Hong-Yang Wang (王红阳)

-	Pathology of Hepatocellular Carcinoma		Wen-ming Cong (丛文铭)
-	Molecular Carcinogenesis and Targeted Gene Therapeutics for HCC		Ju-sheng Lin (林菊生)
-	Proteomics of HCC		Yin-kun Liu (刘银坤)
-	Pathogenesis of Cholangiocarcinoma		Sum P. Lee (李心平)
-	Antisense Approach for Treatment to HCC		Hong Zhang (张紅)
-	The Epigenetic Aberration in Hepatocellular Carcinoma: DNA Methylation and Small Non-coding RNAs		Jing-de Zhu (朱景德)
-	Monoclonal Antibody for HCC		Zhi-nan Chen (陈志南)
-	Interferon a Inhibits Metastasis and Recurrence of Hepatocellular Carcinoma and its Related Mechanism		Lu Wang (王鲁)

Moderators: Takafumi Ichida, Shu-Sen Zhen (郑树森)

-	Recurrent Hepatitis C after Liver Transplantation		Peter Ferenci
-	Right Lobe Liver Transplantation		Chi-leung Liu (廖子良)
-	Hepatitis B and Liver Transplantation		Kyung-Suk Suh
-	Outcome of OLT in HCV/HIV Coinfection Patients		Edward J.Gane
-	Mechanism of HCV Recurrence after Liver Transplantation		Geoffrey W. McCaughan
-	Adult-to-Adult Living Doner Liver Transplantion:Our Experience		Lu-nan Yan (严律南)

Moderators: Chien-jen Chen (陳建仁), Marion G.Peters

-	Antiviral-resistant Hepatitis B - How To Deal with This New Monster?		Anna S.F. Lok (駱淑芳)
-	Genotype in China and Drug Resistance		Jun Cheng (成军)
-	Clinical Impact of HBV Genotype in Asia		Henry L.Y. Chan (陈力元)
-	Relevance of HCV Variants and Genotype		Michael P. Manns
-	Vaccine-induced Escape Mutant		Daniel Shouval
-	What is the Influence of Core/Precore Promotor Mutation on HBV Viremia		Wan-Cheng Chow

Morderators: Stephen A.Locarnini,Joseph J.Y. Sung (沈祖尧)

-	ACTG Study for HIV-HBV Co-infection		Marion G. Peters
-	HBV/HCV Coinfection In A Cohort Of HIV-infected Paid Blood Donors From Henan Province Of China		Feng-min Lu (鲁凤民)
-	Delivering Antiretroviral Therapy in China: Progress and Challenges		Fu-jie Zhang (张福杰)
-	Development of Therapeutic Strategy fo HIV-HBV Co-infection		Gregory Dore
-	Immunopathogenesis of HIV-HBV Co-infection		Sharon Lewin

Moderators: Henry L.Y. Chan (陈力元), Min-de Zeng (曾民德)

-	HBV Genotype is of Clinical Implication (Pro)		Jia-horng Kao (高嘉宏)
-	HBV Genotype is of Clinical Implication (Con)		Jin-lin Hou (侯金林)

Moderators: Wan-cheng Chow (周蕴菁), Teerha Piratvisuth

-	Life-long Nuc Therapy is Unethical (Pro)		Eugene R. Schiff
-	Life-long Nuc Therapy is Unethical (Con)		Nancy W.Y. Leung (梁慧仪)

Moderators: Chien-jen Chen (陈建仁), Masao Omata

-	Serological Clearance of HBsAg Is the Best Treatment Endpoint for Chronic HBV Infection (Pro)		Anna S.F. Lok (駱淑芳)
-	Serological Clearance of HBsAg Is the Best Treatment Endpoint for Chronic HBV Infection (Con)		Ching-lung Lai (黎青龙)

Moderators: Joseph W.Y. Lau (刘允怡), Sum P. Lee (李心平)

-	Treatment Strategy and Efficacy of Radiofrequency Ablation for Hepatic Tumors in Hazardous Locations		Min-hua Chen (陈敏华)
-	Evidence-based Approach of the Treatment Strategy for Hepatocellular Carcinoma		Josep M. Llovet
-	Role of Portal Vein Embolization in Hepatotectomy in Cirrhotic Patients		Chi-leung Liu (廖子良)
-	Liver Transplantation for Patients with Liver Malignancy:Prognostic Factor Prediticing Tumor-Free Survival		Jia Fan (樊嘉)
-	Living Donor Liver Transplantation :Clinical Experience in Mainland China		Xue-hao Wang (王学浩)
-	Resection of Caudate Lobe of Liver (A Report of 118 Cases)		Shu-you Peng (彭叔牖)

Moderators: Kwang-Hyub Han, Fan Jia （樊嘉）

-	Treatment for Advanced HCC: from IVR Treatment to Liver Transplantation		Takafumi Ichida
-	Laparoscopic Liver Resection: Experience of 23 Procedures		Hong-wei Li (李宏为)
-	Salvage liver transplantation is an alternative treatment for HCC after liver resection		Shuang-jian Qiu (邱双健)
-	Preconditioning by MARS before OLT		Jia-mei Yang (杨甲梅)
-	Experience in Large HCC Resection		Xiao-ping Chen (陈孝平)
-	Experience in Surgical Treatment of HCC		Li Qiang （李强）
-	Liver Transplantation in Korea		Kyung-Suk Suh
-	RFA vs Resection for Small HCC		Min-shan Chen (陈敏山)
-	Personal Experience in Hepatic Transplantation for HCC		Yoshiaki Kita

Moderators: Jun Cheng (成军), Jose D. Sollano

-	HBV Factors and Risk of HCC		Jia-horng Kao (高嘉宏)
-	Dynamics of Hepatitis B Biomarkers as Predictor of Liver Diseases: A Long Term Follow-up Study		Chien-jen Chen (陳建仁)
-	Modeling the Kinetics of Acute HBV Infection		Alan S. Perelson
-	Liver Complications in Relation to Serum Aminotransaminase, HBV DNA and HBeAg Status		Ching-lung Lai (黎青龙)
-	Natural History of HBV Infection in Asians		Dong-jin Suh
-	HBeAg Negative Hepatitis B in China		Jin-lin Hou (侯金林)

Moderators: John M. Luk (陆满清),Rong Zeng (曾荣)

-	Comparative oncogenomics for HCC		Lars Zender
-	Genetic signatures for cancer		Edison T. Liu
-	HCC-related gene: from CGH to tissue microarray		Xin-yuan Guan (关新元)
-	Proteomics in the study of liver pathology		Laura Beretta
-	HCC proteome of clinical correlations		John M. Luk (陆满清)
-	Proteomics profiling of metastatic HCC		Rong Zeng (曾荣)
-	Serum profiling: from liver fibrosis to HCC		Terence C. W. Poon (潘全威)
-	HCC biomarker validation		Jorge Marrero
-	Identification and characterization of peptides that interact with hepatitis B virus via the putative receptor binding site		Yuan Wang (汪垣)

Moderators: Curtis C. Harris, Jian-Ren Gu (顾建人)

-	Biotherapy for HCC		Sheng-long Ye (叶胜龙)
-	Cancer is a Systems Diseases Characterized by Cell Groups Abnormality of the Defined Tissues or Organs		Jian-ren Gu (顾建人)
-	Signal Transduction Pathways		Jack R. Wands
-	90-Yttrium Microsphere		Brian I. Carr
-	Chronic HBV Infection with Hepatitc Progenitor Cell Activation Preceding HCC Detection		Zhong-tang Sun (孙宗棠)
-	Protein Kinase and HCC		Hong-yang Wang (王红阳)

Moderators: Jak-yiu Lai, Lai Wei (魏来)

-	Molecular Virology & the Development of Resistant Mutants		Stephen A. Locarnini
-	Evidence Based Clinical Study on Traditional Chinese Medicine and Herbs for the Treatment of Chronic Hepatitis B and C		Leonard B. Seeff
-	Animal Models of NAFLD and Steatohepatitis		Amin A. Nanji
-	Approach to Patient with Advance Fibrosis		Joseph J.Y. Sung (沈祖尧)
-	Occult HBV Infection: Clinical Implications and Significance		Chee-kin Hui (许志坚)
-	Changing Paradign in the Treatment of HBV Infection		Robert G. Gish

Moderators: Edward J. Gane, Yu-mei Wen (闻玉梅)

-	Metabolic Syndrome and Steatosis in Chronic HCV		Wan-cheng Chow (周蕴菁)
-	Effect of Immunocompromised State on Natural History of HCV		Marion G. Peters
-	Hepatitis C and HCC		Alfredo Alberti
-	Predicting Response to Treatment in Chronic HCV		Peter Ferenci
-	Extrahepatic Manifestations of HCV		Jose D. Sollano
-	Histological Effects of Treatment for Chronic HCV		Karen L. Lindsay
-	HCV Infection in Infants: Clinical Outcome of Mother to Infant Transmission of HCV		Lai Wei (魏来)
-	Maintenance Therapy for HCV Treatment Nonresponders		Anna S.F. Lok (駱淑芳)